Stocks  /  NASDAQ  /  Silexion Therapeutics Corp

Silexion Therapeutics Corp

Industry:   Health Care – Biotechnology: Biological Products (No Diagnostic Substances)

Stock Symbol:   SLXNNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Silexion Therapeutics Corp. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following report that they exploit animals for product testing.

“Relatively few product candidates based on these discoveries have ever been tested in animals or humans.” (Page 10) Read the full document

Company Description

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Company Website: https://www.silexion.com

Contact:  info@silexion.com
Scroll to Top